APO Research
Talk to an analyst

APO RESEARCH · REPORT

mRNA COVID-19 Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global mRNA COVID-19 Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025186 pages

Choose your research edition.

Industry ResearchmRNA COVID-19 Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal mRNA COVID-19 Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal mRNA COVID-19 Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal mRNA COVID-19 Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal mRNA COVID-19 Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global mRNA COVID-19 Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for mRNA COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for mRNA COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for mRNA COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for mRNA COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of mRNA COVID-19 Vaccine include CSPC Pharmaceutical, CanSino Biologicals, Pfizer, Fosun-Pharmaceutical and Moderna, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global mRNA COVID-19 Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of mRNA COVID-19 Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents mRNA COVID-19 Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the mRNA COVID-19 Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

mRNA COVID-19 Vaccine Segment by Company

CSPC Pharmaceutical

CanSino Biologicals

Pfizer

Fosun-Pharmaceutical

Moderna

mRNA COVID-19 Vaccine Segment by Type

Non-replicating mRNA Vaccine

Self-amplifying mRNA Vaccine

mRNA COVID-19 Vaccine Segment by Application

Children

Adults

mRNA COVID-19 Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA COVID-19 Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of mRNA COVID-19 Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA COVID-19 Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the mRNA COVID-19 Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of mRNA COVID-19 Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of mRNA COVID-19 Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of mRNA COVID-19 Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. mRNA COVID-19 Vaccine Industry Trends Table 2. mRNA COVID-19 Vaccine Industry Drivers Table 3. mRNA COVID-19 Vaccine Industry Opportunities and Challenges Table 4. mRNA COVID-19 Vaccine Industry Restraints Table 5. Global mRNA COVID-19 Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global mRNA COVID-19 Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global mRNA COVID-19 Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global mRNA COVID-19 Vaccine Sales Market Share by Manufacturers Table 9. Global mRNA COVID-19 Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global mRNA COVID-19 Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global mRNA COVID-19 Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global mRNA COVID-19 Vaccine Manufacturers, Product Type & Application Table 13. Global mRNA COVID-19 Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global mRNA COVID-19 Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Non-replicating mRNA Vaccine Table 17. Major Manufacturers of Self-amplifying mRNA Vaccine Table 18. Global mRNA COVID-19 Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global mRNA COVID-19 Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026) Table 22. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2027-2032) Table 23. Global mRNA COVID-19 Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global mRNA COVID-19 Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global mRNA COVID-19 Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Children Table 29. Major Manufacturers of Adults Table 30. Global mRNA COVID-19 Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global mRNA COVID-19 Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2026) Table 34. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2027-2032) Table 35. Global mRNA COVID-19 Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global mRNA COVID-19 Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global mRNA COVID-19 Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global mRNA COVID-19 Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global mRNA COVID-19 Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global mRNA COVID-19 Vaccine Sales Market Share by Region (2021-2026) Table 43. Global mRNA COVID-19 Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global mRNA COVID-19 Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America mRNA COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America mRNA COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe mRNA COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe mRNA COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific mRNA COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific mRNA COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa mRNA COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa mRNA COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global mRNA COVID-19 Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global mRNA COVID-19 Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global mRNA COVID-19 Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global mRNA COVID-19 Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global mRNA COVID-19 Vaccine Revenue Market Share by Region (2027-2032) Table 62. CSPC Pharmaceutical Company Information Table 63. CSPC Pharmaceutical Business Overview Table 64. CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio Table 66. CSPC Pharmaceutical Recent Development Table 67. CanSino Biologicals Company Information Table 68. CanSino Biologicals Business Overview Table 69. CanSino Biologicals mRNA COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolio Table 71. CanSino Biologicals Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer mRNA COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pfizer mRNA COVID-19 Vaccine Product Portfolio Table 76. Pfizer Recent Development Table 77. Fosun-Pharmaceutical Company Information Table 78. Fosun-Pharmaceutical Business Overview Table 79. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio Table 81. Fosun-Pharmaceutical Recent Development Table 82. Moderna Company Information Table 83. Moderna Business Overview Table 84. Moderna mRNA COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Moderna mRNA COVID-19 Vaccine Product Portfolio Table 86. Moderna Recent Development Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. mRNA COVID-19 Vaccine Distributors List Table 90. mRNA COVID-19 Vaccine Customers List Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. mRNA COVID-19 Vaccine Product Image Figure 2. Global mRNA COVID-19 Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global mRNA COVID-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global mRNA COVID-19 Vaccine Sales (2021-2032) & (k units) Figure 5. Global mRNA COVID-19 Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 mRNA COVID-19 Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Non-replicating mRNA Vaccine Image Figure 9. Self-amplifying mRNA Vaccine Image Figure 10. Global mRNA COVID-19 Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global mRNA COVID-19 Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global mRNA COVID-19 Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global mRNA COVID-19 Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Children Image Figure 17. Adults Image Figure 18. Global mRNA COVID-19 Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global mRNA COVID-19 Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global mRNA COVID-19 Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global mRNA COVID-19 Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America mRNA COVID-19 Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe mRNA COVID-19 Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific mRNA COVID-19 Vaccine Sales Market Share by Country (2021-2032) Figure 38. China mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa mRNA COVID-19 Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile mRNA COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global mRNA COVID-19 Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global mRNA COVID-19 Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America mRNA COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe mRNA COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific mRNA COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa mRNA COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. mRNA COVID-19 Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. mRNA COVID-19 Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Non-replicating mRNA Vaccine
  • Self-amplifying mRNA Vaccine
Applications
  • Children
  • Adults
Companies covered
  • CSPC Pharmaceutical
  • CanSino Biologicals
  • Pfizer
  • Fosun-Pharmaceutical
  • Moderna

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global mRNA COVID-19 Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global mRNA COVID-19 Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global mRNA COVID-19 Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global mRNA COVID-19 Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global mRNA COVID-19 Vaccine Market Dynamics
  1. 2.1 mRNA COVID-19 Vaccine Industry Trends
  2. 2.2 mRNA COVID-19 Vaccine Industry Drivers
  3. 2.3 mRNA COVID-19 Vaccine Industry Opportunities and Challenges
  4. 2.4 mRNA COVID-19 Vaccine Industry Restraints
3 mRNA COVID-19 Vaccine Market by Manufacturers
  1. 3.1 Global mRNA COVID-19 Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global mRNA COVID-19 Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global mRNA COVID-19 Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global mRNA COVID-19 Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global mRNA COVID-19 Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global mRNA COVID-19 Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global mRNA COVID-19 Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global mRNA COVID-19 Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 mRNA COVID-19 Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 mRNA COVID-19 Vaccine Tier 1, Tier 2, and Tier 3
4 mRNA COVID-19 Vaccine Market by Type
  1. 4.1 mRNA COVID-19 Vaccine Type Introduction
  2. 4.1.1 Non-replicating mRNA Vaccine
  3. 4.1.2 Self-amplifying mRNA Vaccine
  4. 4.2 Global mRNA COVID-19 Vaccine Sales by Type
  5. 4.2.1 Global mRNA COVID-19 Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global mRNA COVID-19 Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global mRNA COVID-19 Vaccine Revenue by Type
  9. 4.3.1 Global mRNA COVID-19 Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global mRNA COVID-19 Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2021-2032)
5 mRNA COVID-19 Vaccine Market by Application
  1. 5.1 mRNA COVID-19 Vaccine Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.2 Global mRNA COVID-19 Vaccine Sales by Application
  5. 5.2.1 Global mRNA COVID-19 Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global mRNA COVID-19 Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global mRNA COVID-19 Vaccine Revenue by Application
  9. 5.3.1 Global mRNA COVID-19 Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global mRNA COVID-19 Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2021-2032)
6 Global mRNA COVID-19 Vaccine Sales by Region
  1. 6.1 Global mRNA COVID-19 Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global mRNA COVID-19 Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global mRNA COVID-19 Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global mRNA COVID-19 Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America mRNA COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America mRNA COVID-19 Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe mRNA COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe mRNA COVID-19 Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific mRNA COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific mRNA COVID-19 Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa mRNA COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa mRNA COVID-19 Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global mRNA COVID-19 Vaccine Revenue by Region
  1. 7.1 Global mRNA COVID-19 Vaccine Revenue by Region
  2. 7.1.1 Global mRNA COVID-19 Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global mRNA COVID-19 Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global mRNA COVID-19 Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global mRNA COVID-19 Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America mRNA COVID-19 Vaccine Revenue (2021-2032)
  8. 7.2.2 North America mRNA COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe mRNA COVID-19 Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe mRNA COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific mRNA COVID-19 Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific mRNA COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa mRNA COVID-19 Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa mRNA COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSPC Pharmaceutical
  2. 8.1.1 CSPC Pharmaceutical Company Information
  3. 8.1.2 CSPC Pharmaceutical Business Overview
  4. 8.1.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio
  6. 8.1.5 CSPC Pharmaceutical Recent Developments
  7. 8.2 CanSino Biologicals
  8. 8.2.1 CanSino Biologicals Company Information
  9. 8.2.2 CanSino Biologicals Business Overview
  10. 8.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolio
  12. 8.2.5 CanSino Biologicals Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer mRNA COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer mRNA COVID-19 Vaccine Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Fosun-Pharmaceutical
  20. 8.4.1 Fosun-Pharmaceutical Company Information
  21. 8.4.2 Fosun-Pharmaceutical Business Overview
  22. 8.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio
  24. 8.4.5 Fosun-Pharmaceutical Recent Developments
  25. 8.5 Moderna
  26. 8.5.1 Moderna Company Information
  27. 8.5.2 Moderna Business Overview
  28. 8.5.3 Moderna mRNA COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Moderna mRNA COVID-19 Vaccine Product Portfolio
  30. 8.5.5 Moderna Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 mRNA COVID-19 Vaccine Value Chain Analysis
  2. 9.1.1 mRNA COVID-19 Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 mRNA COVID-19 Vaccine Production Mode & Process
  6. 9.2 mRNA COVID-19 Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 mRNA COVID-19 Vaccine Distributors
  9. 9.2.3 mRNA COVID-19 Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst